The mammalian target of rapamycin (mTOR) pathway is a therapeutic target in polycystic kidney disease…
karnottFebruary 3, 2025
HDT Bio, a leader in advanced RNA vaccine technologies, is partnering with MalarVx to advance…
karnottJanuary 31, 2025
Washington Research Foundation (WRF) has awarded $93,030 over the next two years to support the…
karnottJanuary 31, 2025
Adaptive Biotechnologies and NeoGenomics have formed a multi-year exclusive commercial collaboration to enhance minimal residual…
karnottJanuary 30, 2025
The Chan Zuckerberg Initiative (CZI) is awarding BBI researchers $1.5 million over two years to…
karnottJanuary 30, 2025
A new study shows that oral fecal microbiota transplantation (FMT) is a feasible and safe…
karnottJanuary 29, 2025
This week, we profile a recent publication in Nature by Dr. Susana Vázquez Torres (pictured) …
karnottJanuary 29, 2025
The human immune system is like an army of specialized soldiers (immune cells) each with…
karnottJanuary 28, 2025
